Calidi Biotherapeutics Inc (AMEX:CLDI) has a beta value of 1.06 and has seen 18.04 million shares traded in the last trading session. The CLDI stock price is -1289.29% off its 52-week high price of $3.89 and 0.0% above the 52-week low of $0.28. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.33 million shares traded. The 3-month trading volume is 390.17K shares.
Calidi Biotherapeutics Inc (AMEX:CLDI) trade information
Sporting 1.60%% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CLDI stock price touched $0.28 or saw a rise of 17.62%. Year-to-date, Calidi Biotherapeutics Inc shares have moved -85.53%, while the 5-day performance has seen it change -17.39%. Over the past 30 days, the shares of Calidi Biotherapeutics Inc (AMEX:CLDI) have changed -29.66%. Short interest in the company has seen 0.29 million shares shorted with days to cover at 1.31.
Wall Street analysts have a consensus price target for the stock at $5.5, which means that the shares’ value could jump 94.91% from current levels. The projected low price target is $2.0 while the price target rests at a high of $9.0. In that case, then, we find that the current price level is -3114.29% off the targeted high while a plunge would see the stock gain -614.29% from current levels.
Calidi Biotherapeutics Inc (CLDI) estimates and forecasts
The company’s shares have lost -83.53% over the past 6 months.
Earnings growth for 2025 is a modest 84.85% while over the next 5 years, the company’s earnings are expected to increase by 53.95%.
CLDI Dividends
Calidi Biotherapeutics Inc is expected to release its next earnings report on 2025-May-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Calidi Biotherapeutics Inc (AMEX:CLDI)’s Major holders
Insiders own 6.81% of the company shares, while shares held by institutions stand at 17.24% with a share float percentage of 18.50%. Investors are also buoyed by the number of investors in a company, with Calidi Biotherapeutics Inc having a total of 39.0 institutions that hold shares in the company. The top two institutional holders are RED WAVE INVESTMENTS LLC with over 0.62 million shares worth more than $0.12 million. As of 2024-06-30, RED WAVE INVESTMENTS LLC held 1.1723% of shares outstanding.
The other major institutional holder is CPR INVESTMENTS INC., with the holding of over 0.56 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.11 million and represent 1.0511% of shares outstanding.
